Purchases and Sales Made in Q2 2021 in Vista Gen Therapeutics, Inc. (VTGN)
This table provides information about the institutional ownership of Vista Gen Therapeutics, Inc. (VTGN) during Q2 2021. The information is specifically focused on institutions that hold shares of VistaGen Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 16, 2021
Q2 2021
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-568K- 4.62% |
$1.11M - $1.79M
|
11.7M
$34.6M
|
|
|
Aug 13, 2021
Q2 2021
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-925K- 8.52% |
$1.81M - $2.91M
|
9.94M
$29.3M
|
|
|
Aug 13, 2021
Q2 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.06MClosed |
$2.08M - $3.35M
|
0
$0
|
|
|
Aug 17, 2021
Q2 2021
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-1.1M- 60.0% |
$2.15M - $3.46M
|
733K
$2.16M
|
|
|
Aug 16, 2021
Q2 2021
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.22M- 87.35% |
$2.39M - $3.84M
|
177K
$521K
|
|
|
Aug 16, 2021
Q2 2021
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-1.97M- 68.24% |
$3.86M - $6.2M
|
917K
$2.7M
|
|
|
Aug 11, 2021
Q2 2021
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-2.14M- 51.73% |
$4.2M - $6.75M
|
2M
$5.9M
|